UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): ~~February~~March 2617, 2026

Cycurion, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

001-41214

86-3720717

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)

1640 Boro Place, Suite 420C McLean, Virginia

(Address of principal executive offices)

22102

(Zip Code)

Registrant’s telephone number, including area code: (888) 341-6680

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common stock, par value $0.0001 per share

CYCU

The NASDAQ Stock Market LLC

Redeemable warrants, each exercisable for one share of common stock at an exercise price of $345.00 per share

CYCUW

The NASDAQ Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 5.07 Submission of Matters to a Vote of Security Holders

On March 19, 2026, Cycurion, Inc. (the “Company”) held a special meeting of stockholders (the “Special Meeting”) to vote on the proposals identified in the proxy statement filed with the U.S. Securities and Exchange Commission and mailed to stockholders on February 2, 2026. As of the record date on January 21, 2026, there were a total of 5,148,411 shares of Voting Stock (as defined below) issued and outstanding, consisting of 4,188,187 shares of common stock, par value $0.0001 per share (the “Common Stock”), and 960,224 shares of preferred stock, par value $0.0001 per share, having voting rights on as as-if-converted-to-Common Stock basis (the “Preferred Voting Stock”, and together with the Common Stock, the “Voting Stock”), each of which is entitled to one vote. A total of 2,611,518 shares of the Company’s Voting Stock were represented at the Special Meeting either in person or by proxy. At the Special Meeting, the Company’s stockholders voted on the following matters and cast their votes as described below.

Proposal 1 - The Warrant Exercise Proposal - A proposal to approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 3,314,920 shares of Common Stock upon the exercise of certain Common Stock purchase warrants issued in connection with our private placement that closed on December 5, 2025, that may be equal to or exceed 20% of our outstanding shares of Common Stock immediately prior to such offering (the “Warrant Exercise Proposal”).


FOR	AGAINST	ABSTAIN	NON-VOTES
2,359,348	164,438	5,773	81,959

Proposal 2 – Adjournment Proposal - A proposal to approve an adjournment of the Special Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the Warrant Exercise Proposal (the “Adjournment Proposal”).


FOR	AGAINST	ABSTAIN	NON-VOTES
2,460,423	143,588	7,207	0

Item 8.01 Other Events.

On ~~February~~March 2617, 2026, ~~Cycurion, Inc. (“Cycurion” or~~ the “Company”) issued a press release. ~~announcing~~A ~~that~~copy ~~the Company adjourned its special meeting~~ of ~~stockholders (~~the ~~“Special~~press ~~Meeting”)~~release ~~until~~is ~~Thursday,~~furnished ~~March~~as ~~19,~~Exhibit ~~2026 at 12:00 p~~99.m.1 ~~Eastern Time in order~~ to ~~provide~~this ~~Cycurion~~Current ~~stockholders~~Report ~~with~~on ~~additional~~Form ~~time to cast their votes~~8-K. ~~The Special Meeting was originally scheduled for February 26, 2026; however, the number of votes cast was less than the number of shares required to constitute a quorum for the Special Meeting.~~

The purpose of the Special Meeting is for Cycurion stockholders to, among other things, approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 3,314,920 shares of the Company’s common stock upon the exercise of certain common stock purchase warrants issued in connection with our private placement that closed on December 5, 2025, that may be equal to or exceed 20% of our outstanding shares of common stock immediately prior to such offering. The proposals to be voted on by the Cycurion stockholders at the adjourned Special Meeting are more fully described in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on February 2, 2026.

The record date for the Special Meeting remains January 21, 2026 and will apply to the reconvened Special Meeting on March 19, 2026. Proxies previously submitted in respect of the Special Meeting will be voted at the reconvened Special Meeting unless properly revoked. Stockholders who have previously submitted their proxy or otherwise voted need not take any action. For stockholders who have not yet cast their votes, Cycurion encourages them to vote their shares now. Instructions for how to vote by proxy at the meeting, even if a stockholder is unable to attend the meeting, are included in the definitive proxy statement. For more information on how to vote, please contact Cycurion’s proxy solicitor, D.F. King & Co., Inc.

A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits

(d)Exhibits:

Exhibit No.						Description
99.1						Press Release dated ~~February~~March 2617, 2026
104						Inline XBRL for the cover page of this Current Report on Form 8-K

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CYCURION, INC.
Date:	~~February~~March 2720, 2026	By:	/s/ L. Kevin Kelly
		Name:	L. Kevin Kelly
		Title:	Chief Executive Officer

Filing Compare · Cycurion, Inc.